Biomea Fusion Management
Management criteria checks 2/4
Biomea Fusion's CEO is Mick Hitchcock, appointed in Mar 2025, has a tenure of less than a year. directly owns 0.04% of the company’s shares, worth $32.70K. The average tenure of the management team and the board of directors is 3.7 years and 2.1 years respectively.
Key information
Mick Hitchcock
Chief executive officer
US$241.5k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.04% |
| Management average tenure | 3.7yrs |
| Board average tenure | 2.1yrs |
Recent management updates
Recent updates
We're Keeping An Eye On Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
Sep 30
We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully
Jun 10We Think Biomea Fusion (NASDAQ:BMEA) Can Afford To Drive Business Growth
Feb 22Is Biomea Fusion (NASDAQ:BMEA) In A Good Position To Invest In Growth?
Nov 07We Think Biomea Fusion (NASDAQ:BMEA) Needs To Drive Business Growth Carefully
Jul 12Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation
Mar 29We're Hopeful That Biomea Fusion (NASDAQ:BMEA) Will Use Its Cash Wisely
Nov 03Biomea Fusion GAAP EPS of -$0.59 beats by $0.01
Aug 01We're Not Very Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Rate
Jul 20Biomea Fusion (NASDAQ:BMEA) Is In A Good Position To Deliver On Growth Plans
Mar 16Here's Why We're Not Too Worried About Biomea Fusion's (NASDAQ:BMEA) Cash Burn Situation
Nov 27Biomea Fusion: Patience Warranted
Sep 23CEO
Mick Hitchcock (74 yo)
less than a year
Tenure
US$241,496
Compensation
Dr. Michael J. M. Hitchcock, Ph D., also known as Mick, serves as Director at Click Bio Inc. He has been a Director at Biomea Fusion, Inc. since March 2021 & serves as it's Interim CEO since March 25, 2025...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | less than a year | US$241.50k | 0.040% $ 32.7k | |
| Co-Founder | 7.8yrs | US$1.98m | 5.46% $ 4.5m | |
| Chief Technology & Quality Officer | 4.5yrs | no data | no data | |
| Chief People Officer | no data | no data | no data | |
| Executive Vice President of Chemistry | 4.7yrs | no data | no data | |
| Chief Development Officer | 3.3yrs | no data | no data | |
| Executive Vice President of Intellectual Property | 4.1yrs | no data | no data | |
| Chief Medical Officer | 1.8yrs | US$4.17m | 0.00093% $ 761.7 | |
| Senior Vice President of Contracts | 1.3yrs | no data | no data |
3.7yrs
Average Tenure
63yo
Average Age
Experienced Management: BMEA's management team is considered experienced (3.7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Interim CEO & Director | 4.2yrs | US$241.50k | 0.040% $ 32.7k | |
| Co-Founder | 7.8yrs | US$1.98m | 5.46% $ 4.5m | |
| Independent Lead Director | 4.4yrs | US$255.00k | 0.00053% $ 434.1 | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Independent Director | 2.9yrs | US$224.00k | 0% $ 0 | |
| Independent Director | 4.4yrs | US$229.00k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$235.50k | 0% $ 0 | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | 1.3yrs | no data | no data | |
| Member of Scientific Advisory Board | 1.3yrs | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data | |
| Member of Scientific Advisory Board | less than a year | no data | no data |
2.1yrs
Average Tenure
60yo
Average Age
Experienced Board: BMEA's board of directors are not considered experienced ( 2.1 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/04 16:50 |
| End of Day Share Price | 2025/05/02 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Biomea Fusion, Inc. is covered by 14 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Lawson | Barclays |
| Naureen Quibria | Capital One Securities, Inc. |
| Yigal Nochomovitz | Citigroup Inc |